News & InsightsNewsletterLegislation Hub

Foresight

Foresight
AboutContactLog in
Book a Demo
Foresight logo
All News & Insights

REACH Grants Key Authorisations for 4-tert-OPnEO, 4-NPnEO

REACH
24
January 2024
•
383
Dr Steven Brennan
Used in buffer solutions for antigen production and quality control in both veterinary and human health laboratory settings.
Holding a test tube
Quick prompts

AI Generated

Get to the point quicker with prompts - a smarter way to get the information you need from our articles.

Summarise this article

AI Assistant

This feature and much more is available on our platform. If you would like early access, please leave your email and we'll get in touch.

We'll be in touch when the Assistant is ready.
Oops! Something went wrong while submitting the form.
Mountains

The European Commission has released its decisions on the authorisation for the market placement and use of certain substances listed in Annex XIV to Regulation (EC) No 1907/2006. This regulation, which forms the backbone of the European Union's chemical management policy, is commonly known as REACH (Registration, Evaluation, Authorisation, and Restriction of Chemicals). The recent decisions, published under the reference C/2023/1425, mark a crucial step in balancing the socio-economic benefits of these chemicals against the potential risks to human health and the environment.

Decision Overview

One of the key decisions (C(2023) 8143) made on December 1, 2023, concerns two substances:

  • 4-(1,1,3,3-Tetramethylbutyl)phenol, Ethoxylated (4-tert-OPnEO)
  • 4-Nonylphenol, Branched and Linear, Ethoxylated (4-NPnEO)

Both these substances are authorised for use in buffer solutions for antigen production and quality control in both veterinary and human health laboratory settings.

Authorisation Details

Holder of Authorisation: Prionics Lelystad B.V., based in Lelystad, Flevoland, the Netherlands.

Authorisation Numbers: REACH/23/34/0 and REACH/23/34/1.

Authorised Use: Both 4-tert-OPnEO and 4-NPnEO are authorised as components in buffer solutions. These solutions are essential in antigen production processes like cell extraction, cell lysis, and the coating of biological antigens. They are also pivotal in the inactivation of microorganisms that produce targeted antigens and solvent exchange. Furthermore, they are used in the in-process and final quality control of antigens intended for scientific research and development, as well as in vitro diagnostic applications in both veterinary and human health sectors.

Date of Expiry of Review Period: 4 January 2033.

Rationale Behind the Decision

The European Commission's decision to grant these authorisations aligns with Article 60(4) of the REACH Regulation. This article mandates that authorisations can be granted if the socio-economic benefits of using the substance outweigh the risks posed to human health and the environment. Moreover, it necessitates that there should be no suitable alternative substances or technologies available.

This decision underscores the importance of continuous evaluation and monitoring of chemical substances used in critical industries like healthcare and research. Stakeholders, especially those in the pharmaceutical and biotechnological sectors, must ensure compliance with the specific conditions under which these authorisations are granted. They should also stay informed about potential alternatives as they become available, in line with the evolving landscape of chemicals legislation.

Read the source story

The European Commission has released its decisions on the authorisation for the market placement and use of certain substances listed in Annex XIV to Regulation (EC) No 1907/2006. This regulation, which forms the backbone of the European Union's chemical management policy, is commonly known as REACH (Registration, Evaluation, Authorisation, and Restriction of Chemicals). The recent decisions, published under the reference C/2023/1425, mark a crucial step in balancing the socio-economic benefits of these chemicals against the potential risks to human health and the environment.

Read this article now for free!

You have read 3 articles.
Create a free account
or
Log in
to finish reading this article now.

Subscribe to our weekly digest

Sign up to receive our newsletter every Tuesday and get access to all of our content.

By creating an account, you agree to the Terms of Service and Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
This is some text inside of a div block.

Trusted by professionals at

Dupont
ECHA - European Chemicals Agency
Energizer
Chemours
This is some text inside of a div block.

Get Foresight Today

Stay compliant, reduce risk, and protect your business with our AI-powered chemical policy monitoring—tailored just for you.

Global monitoring of 1,200+ sources
Expert-reviewed, trusted regulatory alerts
Instant risk identification for 350k+ substances

Ready to supercharge your policy monitoring workflow?

We’ll be in touch soon with more details and support to help you get started.
Oops! Something went wrong while submitting the form.
Share with a friend
Copy link

Related Articles

Bath tapECHA Opens Second Public Consultation on Chromium (VI) Restriction Impacting EU Manufacturers

June 18, 2025

Chemicals manufacturingEU Scientists Urge REACH Revision to Tackle Chemical Mixture Risks

June 6, 2025

EU ParliamentEU Lawmakers Clash Over PFAS Ban Plans in ENVI Committee Debate

May 16, 2025

Foresight regulatory experts
Streamline your chemical compliance
Easy-to-use product compliance management for small and mid-sized manufacturers — mitigate risk and protect market access.
Get started
Subscribe to Foresight's newsletter
Stay ahead with the latest news & insights
Join 1,000s of compliance professionals getting the latest insights right to their inbox for free, every Tuesday.
100% free. No spam. Unsubscribe any time.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Stay ahead with the latest news & insights
Subscribe to our free weekly newsletter covering news, events, and expert insights.

Related articles

Bath tap

ECHA Opens Second Public Consultation on Chromium (VI) Restriction Impacting EU Manufacturers

ECHA’s new Chromium (VI) restriction proposal enters public consultation, potentially reshaping compliance for manufacturers across Europe.

18

Jun 2025

REACH
Chemicals manufacturing

EU Scientists Urge REACH Revision to Tackle Chemical Mixture Risks

Leading scientists call on the EU to include a Mixture Assessment Factor in REACH, aiming to protect health and ecosystems from combined chemical exposure.

6

Jun 2025

REACH
EU Parliament

EU Lawmakers Clash Over PFAS Ban Plans in ENVI Committee Debate

Debate over PFAS ban intensifies as EU Commission and MEPs discuss REACH reform and industrial exemptions in May ENVI meeting.

16

May 2025

REACH
Foresight
Providing critical insights, analysis, and guidance to help businesses anticipate changes, make informed decisions, and stay ahead.
News & Insights
Newsletter
Legislation Hub
Coverage
Contact
About
© 2025 Foresight. All rights reserved.
SitemapTerms of servicePrivacy policyCookie policy